Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Revenue

Viridian Therapeutics had revenue of $288.00K in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $72.00K. In the year 2023, Viridian Therapeutics had annual revenue of $314.00K.

• Revenue (ttm): $288.00K
• Revenue Growth: -82.59%
• P/S Ratio: 3,206.64
• Revenue / Employee: $3,064
• Employees: 94
• Market Cap: 923.51M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	314.00K	-1.46M	-82.28%
Dec 31, 2022	1.77M	-1.19M	-40.20%
Dec 31, 2021	2.96M	1.91M	182.19%
Dec 31, 2020	1.05M	-3.41M	-76.46%
Dec 31, 2019	4.46M	-3.93M	-46.80%
Dec 31, 2018	8.39M	4.38M	109.49%
Dec 31, 2017	4.00M	526.00K	15.13%
Dec 31, 2016	3.48M	939.00K	37.00%
Dec 31, 2015	2.54M	-1.78M	-41.25%
Dec 31, 2014	4.32M	4.00K	0.09%
Dec 31, 2013	4.32M	-90.04K	-2.04%
Dec 31, 2012	4.41M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.